• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to trans-Piperidine-3,4-diol Hydrochloride (CAS No. 443648-97-3)

trans-Piperidine-3,4-diol hydrochloride (CAS No. 443648-97-3) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as (1R,2S)-1,2-piperidine diol hydrochloride, is a chiral molecule with potential applications in the development of novel therapeutic agents. The unique structural features of trans-piperidine-3,4-diol hydrochloride make it an attractive candidate for various biochemical and pharmacological studies.

The chemical structure of trans-piperidine-3,4-diol hydrochloride consists of a piperidine ring with two hydroxyl groups attached to adjacent carbon atoms in a trans configuration. The presence of these functional groups imparts specific chemical and biological properties to the molecule, making it suitable for a wide range of applications. The hydrochloride salt form enhances its solubility and stability, which are crucial factors in pharmaceutical formulations.

Recent studies have highlighted the potential of trans-piperidine-3,4-diol hydrochloride in modulating various biological pathways. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound can act as a potent inhibitor of specific enzymes involved in inflammatory responses. This property makes it a promising lead compound for the development of anti-inflammatory drugs. Additionally, its ability to cross the blood-brain barrier has been explored for potential neuroprotective applications.

In the context of drug discovery, trans-piperidine-3,4-diol hydrochloride has been utilized as a building block in the synthesis of more complex molecules. Its chiral nature allows for the creation of enantiomerically pure compounds, which are essential in pharmaceuticals to ensure efficacy and minimize side effects. The compound's versatility in synthetic chemistry is further demonstrated by its use in the preparation of prodrugs and drug conjugates.

Clinical trials involving trans-piperidine-3,4-diol hydrochloride are currently underway to evaluate its safety and efficacy in treating various conditions. Preliminary results have shown promising outcomes, particularly in reducing inflammation and improving cognitive function in animal models. These findings underscore the compound's potential as a therapeutic agent and warrant further investigation.

The synthesis of trans-piperidine-3,4-diol hydrochloride involves several steps, including the formation of the piperidine ring and the introduction of the hydroxyl groups. Advanced synthetic methods have been developed to optimize yield and purity, ensuring that the final product meets stringent quality standards required for pharmaceutical applications. Techniques such as asymmetric synthesis and catalytic hydrogenation are commonly employed to achieve high enantiomeric excess.

In addition to its direct therapeutic applications, trans-piperidine-3,4-diol hydrochloride has been studied for its potential as a research tool. Its ability to interact with specific proteins and receptors makes it valuable for probing cellular processes and signaling pathways. This utility extends to areas such as drug target validation and high-throughput screening assays.

The environmental impact of trans-piperidine-3,4-diol hydrochloride is also an important consideration. Green chemistry principles are increasingly being applied to its synthesis to minimize waste generation and reduce environmental footprint. Sustainable production methods not only align with regulatory requirements but also contribute to the overall sustainability of pharmaceutical manufacturing processes.

In conclusion, trans-piperidine-3,4-diol hydrochloride (CAS No. 443648-97-3) is a multifaceted compound with significant potential in both research and clinical settings. Its unique chemical structure and biological properties make it an attractive candidate for developing novel therapeutic agents and advancing our understanding of complex biological systems. Ongoing research continues to uncover new applications and optimize its use in various fields.

• 64051-79-2(3-Hydroxypiperidine hydrochloride)
• 135501-61-0((3R,4S)-piperidine-3,4-diol)
• 475058-41-4((3S)-piperidin-3-ol hydrochloride)
• 13042-55-2(Piperidine-3,4,5-triol)
• 443648-89-3(cis-3,4-piperidinediol hydrochloride)
• 39640-70-5(cis-Piperidine-3,4-diol)
• 39640-71-6(trans-piperidine-3,4-diol)
• 198976-43-1((R)-3-Hydroxypiperidine hydrochloride)
• 280745-41-7((3S,4S,5S,6S)-3,4,5,6-Tetrahydroxyazepane hydrochloride)
• 178964-40-4((3R,4R,5R,6R)-3,4,5,6-Tetrahydroxyazepane Hydrochloride)